mRNA vaccine in cancer therapy: Current advance and future outlook

Citations Over TimeTop 1% of 2023 papers

Abstract

Messenger ribonucleic acid (mRNA) vaccines are a relatively new class of vaccines that have shown great promise in the immunotherapy of a wide variety of infectious diseases and cancer. In the past 2 years, SARS-CoV-2 mRNA vaccines have contributed tremendously against SARS-CoV2, which has prompted the arrival of the mRNA vaccine research boom, especially in the research of cancer vaccines. Compared with conventional cancer vaccines, mRNA vaccines have significant advantages, including efficient production of protective immune responses, relatively low side effects and lower cost of acquisition. In this review, we elaborated on the development of cancer vaccines and mRNA cancer vaccines, as well as the potential biological mechanisms of mRNA cancer vaccines and the latest progress in various tumour treatments, and discussed the challenges and future directions for the field.

Related Papers

• → Cancer Immunotherapy: A Treatment for the Masses(2004)611 cited
• → Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets(2022)102 cited
• → Tackling Resistance to Cancer Immunotherapy: What Do We Know?(2020)15 cited
• → Recent trends in cancer immunotherapy: Pathways and inhibitors(2022)
• → Immunotherapy for Cancer: Harnessing the Power of the Immune System(2023)